4.10Open4.10Pre Close0 Volume2 Open Interest5.00Strike Price0.00Turnover194.39%IV11.38%PremiumAug 16, 2024Expiry Date3.17Intrinsic Value100Multiplier12DDays to Expiry0.93Extrinsic Value100Contract SizeAmericanOptions Type0.9366Delta0.0415Gamma2.49Leverage Ratio-0.0147Theta0.0016Rho2.34Eff Leverage0.0019Vega
INmune Bio Stock Discussion
• $SpringWorks Therapeutics(SWTX.US)$ +19.2% (Nirogacestat Achieved Primary and All Key Secondary Endpoints in Phase3DeFi Trial )
• $Roivant Sciences(ROIV.US)$ +7.1% (FDA has approved VTAMA (tapinarof) cream)
• $Ocugen(OCGN.US)$ +5.9% (announces that it is diversifying its innovative pipeline by introducing a Phase 3 cell therapy platform technology called Ne?Cart)
• $Skyline(SKY.US)$ +4.4% (In reaction to earnings)
• $NetEase(NTES.US)$ +4.1% (In...
No comment yet